190 related articles for article (PubMed ID: 28887209)
1. Thyroid-associated orbitopathy and tears: A proteomics study.
Kishazi E; Dor M; Eperon S; Oberic A; Hamedani M; Turck N
J Proteomics; 2018 Jan; 170():110-116. PubMed ID: 28887209
[TBL] [Abstract][Full Text] [Related]
2. Proteomics Differentiate Between Thyroid-Associated Orbitopathy and Dry Eye Syndrome.
Matheis N; Grus FH; Breitenfeld M; Knych I; Funke S; Pitz S; Ponto KA; Pfeiffer N; Kahaly GJ
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2649-56. PubMed ID: 25829418
[TBL] [Abstract][Full Text] [Related]
3. Tears as a Source of Biomarkers in the Diagnosis of Graves' Orbitopathy.
Bajkowska D; Szelachowska M; Buczyńska A; Krętowski AJ; Siewko K
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358969
[TBL] [Abstract][Full Text] [Related]
4. Proteomics of tear fluid in thyroid-associated orbitopathy.
Matheis N; Okrojek R; Grus FH; Kahaly GJ
Thyroid; 2012 Oct; 22(10):1039-45. PubMed ID: 22873942
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the global protein content from healthy human tears.
Dor M; Eperon S; Lalive PH; Guex-Crosier Y; Hamedani M; Salvisberg C; Turck N
Exp Eye Res; 2019 Feb; 179():64-74. PubMed ID: 30321513
[TBL] [Abstract][Full Text] [Related]
6. Differential profiling of lacrimal cytokines in patients suffering from thyroid-associated orbitopathy.
Kishazi E; Dor M; Eperon S; Oberic A; Turck N; Hamedani M
Sci Rep; 2018 Jul; 8(1):10792. PubMed ID: 30018377
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy.
Huang D; Xu N; Song Y; Wang P; Yang H
Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):619-25. PubMed ID: 22124787
[TBL] [Abstract][Full Text] [Related]
8. The potential of tear proteomics for diagnosis and management of orbital inflammatory disorders including Graves' ophthalmopathy.
Khazaei H; Khazaei D; Verma R; Ng J; Wilmarth PA; David LL; Rosenbaum JT
Exp Eye Res; 2021 Dec; 213():108813. PubMed ID: 34742692
[TBL] [Abstract][Full Text] [Related]
9. Differentiation between thyroid-associated orbitopathy and Graves' disease by iTRAQ-based quantitative proteomic analysis.
Kang J; Li Y; Zhao Z; Zhang H
FEBS Open Bio; 2021 Jul; 11(7):1930-1940. PubMed ID: 33934566
[TBL] [Abstract][Full Text] [Related]
10. Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis.
Salvisberg C; Tajouri N; Hainard A; Burkhard PR; Lalive PH; Turck N
Proteomics Clin Appl; 2014 Apr; 8(3-4):185-94. PubMed ID: 24488530
[TBL] [Abstract][Full Text] [Related]
11. Comparative proteomic analysis of tear fluid in Graves' disease with and without orbitopathy.
Aass C; Norheim I; Eriksen EF; Børnick EC; Thorsby PM; Pepaj M
Clin Endocrinol (Oxf); 2016 Nov; 85(5):805-812. PubMed ID: 27256639
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a tear protein biomarker panel differentiating between Graves' disease with or without orbitopathy.
Aass C; Norheim I; Eriksen EF; Børnick EC; Thorsby PM; Pepaj M
PLoS One; 2017; 12(4):e0175274. PubMed ID: 28419103
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Graves' ophthalmopathy patients' tear protein spectrum.
Jiang LH; Wei RL
Chin Med J (Engl); 2013 Dec; 126(23):4493-8. PubMed ID: 24286413
[TBL] [Abstract][Full Text] [Related]
14. Changes of lacrimal gland and tear inflammatory cytokines in thyroid-associated ophthalmopathy.
Huang D; Luo Q; Yang H; Mao Y
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4935-43. PubMed ID: 24994866
[TBL] [Abstract][Full Text] [Related]
15. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics.
Zhou L; Beuerman RW; Chan CM; Zhao SZ; Li XR; Yang H; Tong L; Liu S; Stern ME; Tan D
J Proteome Res; 2009 Nov; 8(11):4889-905. PubMed ID: 19705875
[TBL] [Abstract][Full Text] [Related]
16. [Expressions of lysozyme C and lactoferrin in tears of thyroid-associated ophthalmopathy patients].
Jiang L; Mou P; Wei R
Zhonghua Yi Xue Za Zhi; 2015 Mar; 95(10):749-52. PubMed ID: 26080846
[TBL] [Abstract][Full Text] [Related]
17. Proteomics of Orbital Tissue in Thyroid-Associated Orbitopathy.
Matheis N; Lantz M; Grus FH; Ponto KA; Wolters D; Brorson H; Planck T; Shahida B; Pitz S; Pfeiffer N; Kahaly GJ
J Clin Endocrinol Metab; 2015 Dec; 100(12):E1523-30. PubMed ID: 26451909
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human tear proteome reveals differentially abundance proteins in thyroid-associated ophthalmopathy.
Zhou X; Wei R; Wang R
PeerJ; 2022; 10():e13701. PubMed ID: 35846879
[TBL] [Abstract][Full Text] [Related]
19. Ocular surface inflammation, and nerve growth factor level in tears in active thyroid-associated ophthalmopathy.
Yoon JS; Choi SH; Lee JH; Lee SJ; Lee SY
Graefes Arch Clin Exp Ophthalmol; 2010 Feb; 248(2):271-6. PubMed ID: 19844736
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of tears following acupuncture treatment for menopausal dry eye disease by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry.
Liu Q; Liu J; Ren C; Cai W; Wei Q; Song Y; Yu J
Int J Nanomedicine; 2017; 12():1663-1671. PubMed ID: 28280333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
